268 related articles for article (PubMed ID: 17413976)
1. Difficulties in assessing the depth of myometrial invasion in endometrial carcinoma.
Ali A; Black D; Soslow RA
Int J Gynecol Pathol; 2007 Apr; 26(2):115-23. PubMed ID: 17413976
[TBL] [Abstract][Full Text] [Related]
2. Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinoma.
Ismiil ND; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Thomas G; Ackerman I; Covens A; Khalifa MA
Int J Gynecol Pathol; 2007 Jul; 26(3):278-83. PubMed ID: 17581412
[TBL] [Abstract][Full Text] [Related]
3. Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion.
Ismiil N; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Ackerman I; Thomas G; Covens A; Khalifa MA
Ann Diagn Pathol; 2007 Aug; 11(4):252-7. PubMed ID: 17630108
[TBL] [Abstract][Full Text] [Related]
4. Endometrial adenocarcinoma involving adenomyosis without true myometrial invasion is characterized by frequent preceding estrogen therapy, low histologic grades, and excellent prognosis.
Mittal KR; Barwick KW
Gynecol Oncol; 1993 May; 49(2):197-201. PubMed ID: 8504988
[TBL] [Abstract][Full Text] [Related]
5. Low-grade, low-stage endometrioid endometrial adenocarcinoma: a clinicopathologic analysis of 324 cases focusing on frequency and pattern of myoinvasion.
Quick CM; May T; Horowitz NS; Nucci MR
Int J Gynecol Pathol; 2012 Jul; 31(4):337-43. PubMed ID: 22653347
[TBL] [Abstract][Full Text] [Related]
6. Reassessment of myometrial invasion in endometrial carcinoma.
Kaku T; Tsuruchi N; Tsukamoto N; Hirakawa T; Kamura T; Nakano H
Obstet Gynecol; 1994 Dec; 84(6):979-82. PubMed ID: 7970481
[TBL] [Abstract][Full Text] [Related]
7. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
[TBL] [Abstract][Full Text] [Related]
8. Myometrial invasion and lymph node metastasis in endometrioid carcinomas: tumor-associated macrophages, microvessel density, and HIF1A have a crucial role.
Espinosa I; José Carnicer M; Catasus L; Canet B; D'angelo E; Zannoni GF; Prat J
Am J Surg Pathol; 2010 Nov; 34(11):1708-14. PubMed ID: 20962622
[TBL] [Abstract][Full Text] [Related]
9. MR imaging in endometrial carcinoma as a diagnostic tool for the absence of myometrial invasion.
Nakao Y; Yokoyama M; Hara K; Koyamatsu Y; Yasunaga M; Araki Y; Watanabe Y; Iwasaka T
Gynecol Oncol; 2006 Aug; 102(2):343-7. PubMed ID: 16469365
[TBL] [Abstract][Full Text] [Related]
10. Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma: a study of their frequency, associated diagnostic problems, and prognostic significance.
Murray SK; Young RH; Scully RE
Int J Gynecol Pathol; 2003 Oct; 22(4):324-33. PubMed ID: 14501811
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated macrophages correlate with vascular space invasion and myometrial invasion in endometrial carcinoma.
Soeda S; Nakamura N; Ozeki T; Nishiyama H; Hojo H; Yamada H; Abe M; Sato A
Gynecol Oncol; 2008 Apr; 109(1):122-8. PubMed ID: 18289648
[TBL] [Abstract][Full Text] [Related]
12. Transitional cell carcinoma of the endometrium and endometrial carcinoma with transitional cell differentiation.
Lininger RA; Ashfaq R; Albores-Saavedra J; Tavassoli FA
Cancer; 1997 May; 79(10):1933-43. PubMed ID: 9149020
[TBL] [Abstract][Full Text] [Related]
13. Predictors of final histology in patients with endometrial cancer.
Frumovitz M; Singh DK; Meyer L; Smith DH; Wertheim I; Resnik E; Bodurka DC
Gynecol Oncol; 2004 Dec; 95(3):463-8. PubMed ID: 15581947
[TBL] [Abstract][Full Text] [Related]
14. CD10 immunostaining distinguishes atypical polypoid adenomyofibroma (atypical polypoid adenomyoma) from endometrial carcinoma invading the myometrium.
Ohishi Y; Kaku T; Kobayashi H; Aishima S; Umekita Y; Wake N; Tsuneyoshi M
Hum Pathol; 2008 Oct; 39(10):1446-53. PubMed ID: 18619643
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of MR imaging for the prediction of myometrial invasion of endometrial carcinoma.
Chung HH; Kang SB; Cho JY; Kim JW; Park NH; Song YS; Kim SH; Lee HP
Gynecol Oncol; 2007 Mar; 104(3):654-9. PubMed ID: 17095081
[TBL] [Abstract][Full Text] [Related]
16. Association of CD44 isoform immunohistochemical expression with myometrial and vascular invasion in endometrioid endometrial carcinoma.
Stokes GN; Shelton JB; Zahn CM; Kendall BS
Gynecol Oncol; 2002 Jan; 84(1):58-61. PubMed ID: 11748977
[TBL] [Abstract][Full Text] [Related]
17. Reliability of magnetic resonance imaging in assessing myometrial invasion absence in endometrial carcinoma.
Suh DS; Kim JK; Kim KR; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Acta Obstet Gynecol Scand; 2009; 88(9):990-3. PubMed ID: 19636979
[TBL] [Abstract][Full Text] [Related]
18. The significance of tumor involved adenomyosis in otherwise low-stage endometrioid adenocarcinoma.
Hanley KZ; Dustin SM; Stoler MH; Atkins KA
Int J Gynecol Pathol; 2010 Sep; 29(5):445-51. PubMed ID: 20736770
[TBL] [Abstract][Full Text] [Related]
19. Clinical value of intraoperative gross examination in endometrial cancer.
Franchi M; Ghezzi F; Melpignano M; Cherchi PL; Scarabelli C; Apolloni C; Zanaboni F
Gynecol Oncol; 2000 Mar; 76(3):357-61. PubMed ID: 10684710
[TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinoma.
Schwab KV; O'Malley DM; Fowler JM; Copeland LJ; Cohn DE
Gynecol Oncol; 2009 Jan; 112(1):146-9. PubMed ID: 18937970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]